Headlines

FibroGen Stock Plummets 30% In 21 Sessions: Is It Time To Sell?

(VIANEWS) – FibroGen (NASDAQ: FGEN) shares have seen an extraordinary decline of 30.15% over the last 21 sessions, falling from EUR1.36 to EUR0.95, continuing their downward momentum from prior sessions. Even as NASDAQ rose 0.83% to EUR13,928.34 during this time, FibroGen’s performance remains weak with their last closing price being EUR0.93, representing an approximately 96%…

Read More

SmileDirectClub Stock Soars 9% In Early Trading!

(VIANEWS) – SmileDirectClub Stock Rises After Recent Losses SmileDirectClub (NASDAQ: SDC) shares rose 9.37% to EUR0.42, ending their five-day losing streak and contributing 0.87% of growth on Thursday morning to EUR13,933.67 on NASDAQ. Additionally, shares were up in yesterday’s session due to positive momentum. SmileDirectClub recently closed with an average closing price of EUR0.38, 71.56%…

Read More

Nikola Stock Surges 16% At Opening Bell On Thursday: Will It Continue?

(VIANEWS) – Nikola’s stock jumps 16.01% after experiencing a decrease; NASDAQ trends up 0.25% Nikola (NASDAQ:NKLA) experienced an unexpected and dramatic rebound on Thursday, climbing 16.01% to EUR1.01 at 10:25 EST following three consecutive sessions of declines. Meanwhile, the NASDAQ index rose 0.25% to EUR13,848.51 as well. Nikola closed at an all-time low price of…

Read More

Less Than One Hour Before The Market Open, Alnylam Pharmaceuticals Is Down By 5%

(VIANEWS) – The NASDAQ opens in less than one hour and Alnylam Pharmaceuticals‘s pre-market value is already 5.58% down. Alnylam Pharmaceuticals’s last close was $211.65, 12.89% below its 52-week high of $242.97. The last session, NASDAQ ended with Alnylam Pharmaceuticals (ALNY) dropping 0% to $211.65. NASDAQ rose 0.29% to $13,813.58, following the last session’s upward…

Read More